GLP-1 Weight Loss: Why Ozempic Results Often Stick
GLP-1 Clinical Relevance #39Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic CommentaryObservational StudyWeight Regain After DiscontinuationSemaglutideFamily…
GLP-1 Tirzepatide Retinal Disease Risk Clinical Evidence
GLP-1 Clinical Relevance #47Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Retrospective Cohort StudyType 2 DiabetesTirzepatideEndocrinologyAdults With Type 2…
GLP-1 Receptor Agonist Clinical Evidence and Biomarkers
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical TrialReal World EvidenceObesitySemaglutideFamily MedicineAdults with ObesityWeight…
GLP-1 Receptor Agonist Randomized Trial Data
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational Study DesignPancreatitis RiskSemaglutideEndocrinologyAdults…
Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis.
A large Canadian observational study demonstrates medical cannabis real world effectiveness across chronic pain, anxiety, and sleep disorders over 24 weeks. This real-world evidence provides clinicians with practical outcome expectations for sustained…
GLP-1 Receptor Agonist Clinical Evidence: Hims & Hers Scale
GLP-1 Clinical Relevance #44Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic NewsObservationalObesitySemaglutidePrimary CareAdults with ObesityWeight ManagementGLP-1…
GLP-1 Receptor Agonist Evidence: Ozempic vs Mounjaro
GLP-1 Clinical Relevance #49Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic NewsObservationalType 2 DiabetesSemaglutideTirzepatideEndocrinologyAdults with…
GLP-1 Receptor Agonist Side Effects: AI Uncovers New Data
GLP-1 Clinical Relevance #44Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical NewsObservational StudyGLP-1 Side EffectsSemaglutideTirzepatideEndocrinologyAdults…
UK medical cannabis for chronic pain: what 792 current patients reported – Reddit
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Chronic PainPatient OutcomesReal World…